PharmaBoardroom

Global Pharma has Reinvented R&D: Will Canadian Start-Ups…

John L. Wallace of Antibe Therapeutics highlights how Canadian innovation stands to put the country at the forefront of the next wave of global…

Péter Holchacker – Director, AIPM, Hungary

Dr Péter Holchacker, director of the Hungarian Association of Innovative Pharmaceutical Manufacturers (AIPM), shares his insights on the key…

Samir Khalil – Executive Director, PhRMA Middle East &…

Samir Khalil, executive director for the Pharmaceutical Research and Manufacturers of America (PhRMA) Middle East and Africa (MEA), reveals why the US…

Jakub Dvořáček – CEO, AIFP, Czech Republic

Jakub Dvořáček, CEO of the Czech Association of Innovative Pharmaceutical Industry (AIFP), describes the thorough review of the reimbursement…

Hot Topics for MNCs in China

PharmaBoardroom recently analysed the contents of 10 interviews conducted with country managers at multinational pharma companies in China. We found…

GSK CEO Emma Walmsley In Conversation

In conversation at the FT Global Pharmaceutical and Biotechnology Conference in London,* an energetic Emma Walmsley discussed the strategic and…

Ana Raposo – Country Director Gulf Countries, Janssen

Ana Raposo, country director for Gulf Countries at Janssen discusses her role, the main similarities and differences between the various markets…

The Czech Republic’s Long Road Towards Innovation

The Czech Republic is aiming to carve out a space for itself among Europe’s most innovative countries by 2030 as part of the ‘Innovation Strategy…

Hungary: Falling Behind for Innovative Medicines

Hungarian patients currently experience longer wait times and more limited access to subsidised innovative medicines than their neighbours in Bulgaria…